We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

116 hedge funds and large institutions have $596M invested in Aerie Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 40 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

47% more call options, than puts

Call options by funds: $3.53M | Put options by funds: $2.4M

36% more capital invested

Capital invested by funds: $437M → $596M (+$159M)

6% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 18

1% more funds holding

Funds holding: 115 → 116 (+1)

10% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 40

Holders
116
Holders Change
+1
Holders Change %
+0.87%
% of All Funds
3.04%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
19
Increased
36
Reduced
40
Closed
18
Calls
$3.53M
Puts
$2.4M
Net Calls
+$1.12M
Net Calls Change
-$22.1M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$11.6M
2
State Street
State Street
Massachusetts
+$7.6M
3
PHS
PFM Health Sciences
California
+$3.65M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.55M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.92M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$16.8M
2
FCMI
Foresite Capital Management II
California
-$3.92M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$3.55M
4
Barclays
Barclays
United Kingdom
-$3.39M
5
WC
Weatherbie Capital
Massachusetts
-$3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$3.9M +$290K +12,443 +8%
RHJA
27
Rice Hall James & Associates
California
$3.76M +$1.77M +75,857 +97%
DCM
28
DAFNA Capital Management
California
$3.61M -$404K -17,300 -10%
GPCM
29
Granite Point Capital Management
Massachusetts
$3.29M +$1.52M +65,000 +93%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.1M -$39.2K -1,679 -1%
RCMC
31
Rubric Capital Management (Connecticut)
Connecticut
$2.99M +$2.87M +122,790 New
PIM
32
Platinum Investment Management
Australia
$2.97M – – –
HCM
33
Harvey Capital Management
Florida
$2.88M -$79.3K -3,400 -3%
TCIM
34
TIAA CREF Investment Management
New York
$2.53M -$154K -6,619 -6%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$2.34M +$162K +6,955 +8%
Stifel Financial
36
Stifel Financial
Missouri
$2.33M +$125K +5,355 +6%
BI
37
Boulegeris Investments
Georgia
$2.32M +$41.5K +1,780 +2%
ACM
38
Asymmetry Capital Management
California
$2.09M +$1.42K +61 +0.1%
Bank of America
39
Bank of America
North Carolina
$1.94M -$6.58K -282 -0.4%
CCM
40
Convector Capital Management
New York
$1.88M +$1.8M +77,000 New
ARTA
41
A.R.T. Advisors
New York
$1.85M +$1.77M +75,887 New
OAM
42
Oxford Asset Management
United Kingdom
$1.84M +$1.75M +75,169 New
USAA
43
United Services Automobile Association
Texas
$1.79M – – –
BIM
44
BlackRock Investment Management
Delaware
$1.78M -$1.1K -47 -0.1%
CV
45
Clarus Ventures
Massachusetts
$1.53M – – –
CCI
46
Columbus Circle Investors
$1.52M -$310K -13,299 -18%
NFA
47
Nationwide Fund Advisors
Ohio
$1.36M +$473K +20,265 +57%
BCA
48
Benchmark Capital Advisors
New York
$1.36M -$11.7K -500 -0.9%
RJA
49
Raymond James & Associates
Florida
$1.29M -$94.7K -4,057 -7%
Macquarie Group
50
Macquarie Group
Australia
$1.27M -$56.5K -2,421 -4%
1
2
3 4 5

AERI Hedge Fund Activity: Q4 2015 in Review

116 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2015, worth a combined $596M — up 36% from $437M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AERI positions and 18 closed out — a net gain of 1 holder — while 36 added to existing stakes and 40 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $11.6M. The largest seller was Millennium Management, cutting an estimated $16.8M.

  • 116 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2015, up from 115 in Q3 2015.
  • Funds reported $596M of Aerie Pharmaceuticals stock for Q4 2015, up 36% quarter-over-quarter.
  • 19 funds opened new Aerie Pharmaceuticals positions in Q4 2015 and 18 closed out, a net change of +1 holder.
  • The largest Aerie Pharmaceuticals buyer in Q4 2015 was AllianceBernstein, an estimated $11.6M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2015 was Millennium Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2015.